Carrie L Byington1, Jacob Wilkes2, Kent Korgenski2, Xiaoming Sheng3. 1. Department of Pediatrics, University of Utah, Salt Lake City, Utah; and carrie.byington@hsc.utah.edu. 2. Intermountain Healthcare, Pediatric Clinical Programs, Salt Lake City, Utah. 3. Department of Pediatrics, University of Utah, Salt Lake City, Utah; and.
Abstract
BACKGROUND AND OBJECTIVE: Respiratory syncytial virus (RSV) is a common cause of pediatric hospitalization, but the mortality rate and estimated annual deaths are based on decades-old data. Our objective was to describe contemporary RSV-associated mortality in hospitalized infants and children aged <2 years. METHODS: We queried the Healthcare Cost and Utilization Project Kids' Inpatient Database (KID) for 2000, 2003, 2006, and 2009 and the Pediatric Health Information System (PHIS) administrative data from 2000 to 2011 for hospitalizations with International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis codes for RSV infection and mortality. RESULTS: The KID data sets identified 607 937 RSV-associated admissions and 550 deaths (9.0 deaths/10 000 admissions). The PHIS data set identified 264 721 RSV-associated admissions and 671 deaths (25.4 deaths/10 000 admissions) (P < .001 compared with the KID data set). The 2009 KID data set estimated 42.0 annual deaths (3.0 deaths/10 000 admissions) for those with a primary diagnosis of RSV. The PHIS data set identified 259 deaths with a primary diagnosis of RSV, with mortality rates peaking at 14.0/10 000 admissions in 2002 and 2003 and decreasing to 4.0/10 000 patients by 2011 (odds ratio: 0.27 [95% confidence interval: 0.14-0.52]). The majority of deaths in both the KID and PHIS data sets occurred in infants with complex chronic conditions and in those with other acute conditions such as sepsis that could have contributed to their deaths. CONCLUSIONS: Deaths associated with RSV are uncommon in the 21st century. Children with complex chronic conditions account for the majority of deaths, and the relative contribution of RSV infection to their deaths is unclear.
BACKGROUND AND OBJECTIVE:Respiratory syncytial virus (RSV) is a common cause of pediatric hospitalization, but the mortality rate and estimated annual deaths are based on decades-old data. Our objective was to describe contemporary RSV-associated mortality in hospitalized infants and children aged <2 years. METHODS: We queried the Healthcare Cost and Utilization Project Kids' Inpatient Database (KID) for 2000, 2003, 2006, and 2009 and the Pediatric Health Information System (PHIS) administrative data from 2000 to 2011 for hospitalizations with International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis codes for RSV infection and mortality. RESULTS: The KID data sets identified 607 937 RSV-associated admissions and 550 deaths (9.0 deaths/10 000 admissions). The PHIS data set identified 264 721 RSV-associated admissions and 671 deaths (25.4 deaths/10 000 admissions) (P < .001 compared with the KID data set). The 2009 KID data set estimated 42.0 annual deaths (3.0 deaths/10 000 admissions) for those with a primary diagnosis of RSV. The PHIS data set identified 259 deaths with a primary diagnosis of RSV, with mortality rates peaking at 14.0/10 000 admissions in 2002 and 2003 and decreasing to 4.0/10 000 patients by 2011 (odds ratio: 0.27 [95% confidence interval: 0.14-0.52]). The majority of deaths in both the KID and PHIS data sets occurred in infants with complex chronic conditions and in those with other acute conditions such as sepsis that could have contributed to their deaths. CONCLUSIONS: Deaths associated with RSV are uncommon in the 21st century. Children with complex chronic conditions account for the majority of deaths, and the relative contribution of RSV infection to their deaths is unclear.
Authors: Jeffrey D Horbar; Joseph H Carpenter; Gary J Badger; Michael J Kenny; Roger F Soll; Kate A Morrow; Jeffrey S Buzas Journal: Pediatrics Date: 2012-05-21 Impact factor: 7.124
Authors: Jay G Berry; Matt Hall; David E Hall; Dennis Z Kuo; Eyal Cohen; Rishi Agrawal; Kenneth D Mandl; Holly Clifton; John Neff Journal: JAMA Pediatr Date: 2013-02 Impact factor: 16.193
Authors: Tea Andabaka; Jason W Nickerson; Maria Ximena Rojas-Reyes; Juan David Rueda; Vesna Bacic Vrca; Bruno Barsic Journal: Cochrane Database Syst Rev Date: 2013-04-30
Authors: Maximiliane L Verfürden; Tiffany Fitzpatrick; Laura Holder; Ania Zylbersztejn; Laura Rosella; Ruth Gilbert; Astrid Guttmann; Pia Hardelid Journal: CMAJ Open Date: 2020-04-28
Authors: Amy G Feldman; Brenda L Beaty; Donna Curtis; Elizabeth Juarez-Colunga; Allison Kempe Journal: JAMA Pediatr Date: 2019-03-01 Impact factor: 16.193
Authors: Lindsay Kim; Brian Rha; Jon S Abramson; Larry J Anderson; Carrie L Byington; Grace L Chen; John DeVincenzo; Kathryn M Edwards; Janet A Englund; Ann R Falsey; Marie R Griffin; Ruth A Karron; Karen G Martin; H Cody Meissner; Flor M Munoz; Andrew T Pavia; Pedro A Piedra; William Schaffner; Eric A F Simões; Rosalyn Singleton; H Keipp Talbot; Edward E Walsh; Jane R Zucker; Susan I Gerber Journal: Clin Infect Dis Date: 2017-09-15 Impact factor: 9.079
Authors: Erin G Nicholson; Chelsea Schlegel; Roberto P Garofalo; Reena Mehta; Margaret Scheffler; Minghua Mei; Pedro A Piedra Journal: J Infect Dis Date: 2016-05-18 Impact factor: 5.226